189 related articles for article (PubMed ID: 36656536)
1. Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
Appl Biochem Biotechnol; 2023 Jul; 195(7):4116-4133. PubMed ID: 36656536
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis.
Gao Y; Zou T; Liang W; Zhang Z; Qie M
Cancer Gene Ther; 2021 Jun; 28(6):619-633. PubMed ID: 33139818
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p.
Yu L; Luan W; Feng Z; Jia J; Wu Z; Wang M; Li F; Li Z
Dig Liver Dis; 2021 Feb; 53(2):238-244. PubMed ID: 32952069
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
5. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.
Chen J; Lin Y; Jia Y; Xu T; Wu F; Jin Y
J Cell Physiol; 2019 Dec; 234(12):23421-23436. PubMed ID: 31222748
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
8. Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
Chen JB; Zhu YW; Guo X; Yu C; Liu PH; Li C; Hu J; Li HH; Liu LF; Chen MF; Chen HQ; Xiong-Bing Z
J Cell Physiol; 2019 Aug; 234(8):13592-13601. PubMed ID: 30609030
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA HAND2 Antisense RNA 1 Inhibits Colorectal Cancer Development by Sponging microRNA-3118/Leptin Receptor Axis.
Yi C; Zhao C; Peng C
Ann Clin Lab Sci; 2023 Jan; 53(1):82-93. PubMed ID: 36889764
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
[TBL] [Abstract][Full Text] [Related]
12. LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
Li J; Wang AS; Wang S; Wang CY; Xue S; Guan H; Li WY; Ma TT; Shan YX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1022-1029. PubMed ID: 30779068
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
14. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
15. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
[TBL] [Abstract][Full Text] [Related]
16. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
Zhang M; Xu Y; Yin S; Qiu F
Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1.
Gao Z; Li S; Zhou X; Li H; He S
Cancer Med; 2020 Oct; 9(20):7695-7705. PubMed ID: 32862492
[TBL] [Abstract][Full Text] [Related]
18. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
Zhang L; Xia HB; Zhao CY; Shi L; Ren XL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):86-96. PubMed ID: 31957821
[TBL] [Abstract][Full Text] [Related]
19. ELK1/lncRNA-SNHG7/miR-2682-5p feedback loop enhances bladder cancer cell growth.
Wang W; Chen S; Song X; Gui J; Li Y; Li M
Life Sci; 2020 Dec; 262():118386. PubMed ID: 32898531
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis.
Bi HQ; Li ZH; Zhang H
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):567-574. PubMed ID: 32224127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
